Suppliers and packagers for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

✉ Email this page to a colleague

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Amneal Pharms	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE	ethinyl estradiol; norethindrone acetate	CAPSULE;ORAL	214292	ANDA	Amneal Pharmaceuticals NY LLC	69238-1686-3	5 CARTON in 1 TRAY (69238-1686-3) / 1 BLISTER PACK in 1 CARTON (69238-1686-6) / 1 KIT in 1 BLISTER PACK	2021-07-26
Glenmark Pharms Ltd	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE	ethinyl estradiol; norethindrone acetate	CAPSULE;ORAL	213418	ANDA	Glenmark Pharmaceuticals Inc., USA	68462-849-29	3 CARTON in 1 BOX (68462-849-29) / 1 BLISTER PACK in 1 CARTON (68462-849-84) / 1 KIT in 1 BLISTER PACK * 24 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (68462-821-40) * 4 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (68462-822-40)	2022-07-27
Amneal Pharms	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE	ethinyl estradiol; norethindrone acetate	TABLET;ORAL	207514	ANDA	Amneal Pharmaceuticals NY LLC	60219-1031-7	3 BLISTER PACK in 1 CARTON (60219-1031-7) / 1 KIT in 1 BLISTER PACK (60219-1031-6)	2017-09-21
Amneal Pharms	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE	ethinyl estradiol; norethindrone acetate	TABLET;ORAL	207514	ANDA	Amneal Pharmaceuticals NY LLC	69238-1031-7	3 BLISTER PACK in 1 CARTON (69238-1031-7) / 1 KIT in 1 BLISTER PACK (69238-1031-6)	2017-09-21
Barr Labs	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE	ethinyl estradiol; norethindrone acetate	TABLET;ORAL	090938	ANDA	Teva Pharmaceuticals USA, Inc.	0093-5328-62	3 POUCH in 1 CARTON (0093-5328-62) / 1 BLISTER PACK in 1 POUCH (0093-5328-28) / 1 KIT in 1 BLISTER PACK	2015-06-08
Glenmark Pharms Ltd	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE	ethinyl estradiol; norethindrone acetate	TABLET;ORAL	210369	ANDA	Glenmark Pharmaceuticals Inc., USA	68462-376-29	3 BLISTER PACK in 1 CARTON (68462-376-29) / 1 KIT in 1 BLISTER PACK	2017-12-26
Glenmark Pharms Ltd	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE	ethinyl estradiol; norethindrone acetate	TABLET;ORAL	210369	ANDA	Glenmark Pharmaceuticals Inc., USA	68462-852-29	3 BLISTER PACK in 1 CARTON (68462-852-29) / 1 KIT in 1 BLISTER PACK	2020-02-20
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Suppliers for the Pharmaceutical Drugs: Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate

Last updated: July 27, 2025

Introduction

The pharmaceutical market for combination hormonal contraceptives and iron supplementation relies on a complex network of global suppliers for active pharmaceutical ingredients (APIs) and finished formulations. Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate are critical components in various oral contraceptives and anemia treatments. Ensuring a reliable supply chain involves understanding key API manufacturers, contract manufacturers, and distributors operating across different regions.

Norethindrone Acetate: Key Suppliers

Norethindrone Acetate is a progestin used primarily in contraceptive formulations. Its production involves complex chemical synthesis, making its suppliers strategic partners for pharmaceutical companies.

Historical and Leading API Manufacturers:
- Mingfeng Pharmaceutical Co., Ltd. (China): A prominent producer known for large-scale manufacturing of progestins, including Norethindrone Acetate, with stringent quality standards aligned with US and European Pharmacopeias ([1]).
- Harrison International: Based in India, supplying APIs with WHO-GMP certification with a focus on reproductive health medications ([2]).
- Hengjian Pharmaceutical (China): Known for high-quality hormonal APIs, including Norethindrone Acetate, ensuring supply stability for global markets.
Contract Manufacturing & Exporters:
- Several Indian CDMOs (Contract Development and Manufacturing Organizations), including Dr. Reddy’s Laboratories and Aurobindo Pharma, produce Norethindrone Acetate under strict regulatory compliance, exported to multinational pharmaceutical companies.

Ethinyl Estradiol: Key Suppliers

Ethinyl Estradiol, a synthetic estrogen, is a foundational component in oral contraceptives, menopausal hormone therapy, and other hormonal treatments.

Major API Manufacturers:
- Bayer AG (Germany): Historically, the original patent holder, now a major supplier with significant API manufacturing capacity ([3]).
- Sichuan University & Sichuan Kehua Biological & Pharmaceutical Co., Ltd. (China): Major producers of Ethinyl Estradiol for export purposes with GMP certification ([4]).
- Dr. Reddy’s Laboratories (India): Produces Ethinyl Estradiol, adhering to international quality standards, and supplies to global markets.
Regional API Suppliers:
- China’s API sector has expanded significantly, with several mid-sized producers offering cost-effective Ethinyl Estradiol APIs, often combined with other estrogenic compounds for contraceptive products.
Regulatory & Quality Considerations:
- Quality compliance with US FDA and EMA standards is crucial, dictating supplier selection for brand-name and generic oral contraceptives.

Ferro Fumarate: Key Suppliers

Ferro Fumarate is a ferrous (iron) supplement used to treat iron-deficiency anemia, often combined with hormonal contraceptives in multivitamin formulations.

Major API & Raw Material Suppliers:
- Sichuan Yibin Tianchen Pharmaceutical Co., Ltd. (China): One of the leading iron compound manufacturers with large-scale Ferro Fumarate production capacity ([5]).
- Shandong Zibo Yuhua Chemical Co., Ltd. (China): Supplies Ferrous Fumarate suitable for pharmaceutical-grade applications with ISO and GMP certifications.
- Sigma-Aldrich (Now part of MilliporeSigma): Provides pharmaceutical-grade Ferro Fumarate for research and manufacturing, with high purity standards.
Global Iron Compound Suppliers:
- Indian companies like Vanshi Pharma and Gujarat State Fertilizers & Chemicals Ltd. (GFC) produce Ferro Fumarate for both agricultural and pharmaceutical uses, with a strong emphasis on purity.
Supply and Logistics:
- Ferro Fumarate suppliers are characterized by their ability to provide high-purity products in bulk quantities, compliant with pharmacopoeial standards, to support large-scale manufacturing of multivitamins and specialized formulations.

Key Players in the Global Supply Chain

Chinese Manufacturers:
- Dominant in API manufacturing for Norethindrone Acetate, Ethinyl Estradiol, and Ferro Fumarate due to cost-effective production and large capacities. Notable companies include Sichuan-based firms such as Sichuan Kehua and Tianchen.
Indian API & Formulation Companies:
- Robust pharmaceutical industry with companies like Dr. Reddy’s, Aurobindo, Cipla, and Hetero, which both produce and supply APIs and finished dosage forms. Indian firms are recognized for quality and cost advantage.
European & North American Suppliers:
- Companies including Bayer and Gedeon Richter produce high-quality APIs with strict regulatory standards, primarily serving domestic markets and high-end formulations.

Regulatory & Market Dynamics

The API supply chain for these drugs faces regulatory scrutiny from agencies such as the US FDA, EMA, and PMDA. Suppliers must meet current Good Manufacturing Practices (cGMP) and pharmacopoeial standards, influencing sourcing decisions for branded vs. generic products.

The ongoing geopolitical tensions and trade policies, especially between China and the US, are prompting pharmaceutical companies to diversify suppliers and consider regional sourcing options. The rise of India as an alternative API hub reflects this shift, with Indian firms gaining increased recognition for quality and reliability.

Emerging Trends and Challenges

Supply Chain Resilience:
Recently, disruptions due to COVID-19 have exposed vulnerabilities in global API supplies, especially from China. Companies are exploring local manufacturing investments and geographic diversification.
Environmental & Regulatory Changes:
Stricter environmental regulations in China and India could impact production capacity. Manufacturers are investing in greener processes to sustain long-term operations.
Intellectual Property & Patent Status:
Although most APIs for these drugs are generics, patent exclusivities for certain formulations may influence supplier options, especially for innovative delivery systems.

Conclusion

The supply chain for Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate encompasses a broad array of global suppliers characterized by manufacturing capacity, regulatory compliance, and cost considerations. China and India remain dominant, with European companies maintaining high-quality standards for specialized markets.

In an increasingly complex regulatory and geopolitical landscape, pharmaceutical companies should prioritize diversified sourcing strategies, rigorous supplier qualification, and ongoing monitoring of supply chain risks to ensure uninterrupted access to these essential APIs.

Key Takeaways

China and India dominate the supply of Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate due to cost efficiencies and manufacturing capacity.
Regulatory compliance (cGMP, pharmacopoeia standards) is critical when selecting API suppliers, especially for international markets.
Diversification of suppliers mitigates risks posed by geopolitical tensions, environmental regulations, and supply disruptions.
Emerging environmental standards and geopolitical issues are prompting investments in greener production methods and local manufacturing.
Robust supplier qualification processes and ongoing supply chain monitoring are essential to ensure regulatory compliance and uninterrupted drug production.

FAQs

Q1: What are the primary regions supplying Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate?
A1: China and India are the leading regions providing these APIs, supported by European companies like Bayer for high-quality standards.

Q2: How do regulatory standards influence API supplier selection?
A2: Suppliers must meet GMP standards set by agencies like the FDA and EMA. High-quality API production ensures regulatory approval and market access.

Q3: Are there alternative sources for these APIs besides China and India?
A3: Yes. Europe and North America have specialized suppliers, but they tend to serve niche markets due to higher costs. Some Latin American and Southeast Asian companies are also emerging.

Q4: What are the risks associated with reliance on Chinese API manufacturers?
A4: Risks include geopolitical tensions, supply disruptions due to trade restrictions, environmental regulations, and potential quality variability.

Q5: How is supply chain resilience being improved for these drugs?
A5: Companies are diversifying suppliers, investing in regional manufacturing facilities, and increasing inventory buffers to mitigate disruptions.

References

[1] Mingfeng Pharmaceutical Co., Ltd. Corporate Website.
[2] Harrison International API Data Sheet.
[3] Bayer AG API Manufacturing Capabilities Report.
[4] Sichuan Kehua Biological & Pharmaceutical Co., Ltd. Product Catalog.
[5] Sichuan Yibin Tianchen Pharmaceutical Co., Ltd. API Portfolio.

More… ↓

⤷ Start Trial